Fundraising Fox

Vita Therapeutics

Baltimore, US · Founded 2018 · Delaware corporation · 4 known investors

Healthtech

Founders & leadership

Vita Therapeutics was founded in 2018 by Douglas Falk.

DFDouglas Falk
Douglas FalkFounder
VC
Vlad CoricNamed on SEC filing
PL
Pat LaVecchiaNamed on SEC filing

Investors · 4

Early Light VenturesBaltimore · $100K – $500K
Maryland TEDCOUpper Marlboro · $500K – $1.5M
Riptide VenturesBaltimore · $750Kvia Mike Leffer · inferred
TEDCOColumbia

Reported raises · per SEC filings

Form D private placements

$62.9M disclosed across 3 rounds · 2021–2022

▶$30.9MraisedOct 2022 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FalkExecutive Officer, Director
  • Eva ChinDirector
  • Mark NuttallDirector
  • David ChurchillDirector
  • James PeyerDirector
  • Vlad CoricDirector
Offering amount
$30.9M
Amount sold
$30.9M
First sale
Oct 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12MraisedNov 2021 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Pat LaVecchiaDirector
  • James PeyerDirector
  • Vlad CoricDirector
  • Douglas FalkExecutive Officer, Director
  • Faizzan AhmadDirector
Offering amount
$12M
Amount sold
$12M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas FalkExecutive Officer, Director
  • Vlad CoricDirector
  • Pat LaVecchiaDirector
Offering amount
$20M
Amount sold
$20M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Money Moves: Baltimore's Vita Therapeutics raised a $31M Series Btechnical.ly · Oct 2022Vita Therapeutics raises funds for cell therapies developmentpharmaceutical-technology.com · Oct 2022Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancersbusinesswire.com · Oct 2022Good News: Vita Therapeutics Raises $32M, 2 SIL Alums to Each Receive $225K in Funding, Johns Hopkins 5th in Patents Awarded and More - Johns Hopkins Technology Venturesventures.jhu.edu · Jul 2021Vita Raises $32M to Advance Cell Therapies for LGMD, Other Dystrophiesmusculardystrophynews.com · Jun 2021Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophiesbusinesswire.com · Jun 2021

Frequently asked questions

Who founded Vita Therapeutics?
Vita Therapeutics was founded by Douglas Falk in 2018.
Who are Vita Therapeutics's investors?
Vita Therapeutics's investors include Early Light Ventures, Maryland TEDCO, Riptide Ventures, TEDCO.
How much funding has Vita Therapeutics raised?
Vita Therapeutics has disclosed $62.9M raised across 3 rounds.
Where is Vita Therapeutics headquartered?
Vita Therapeutics is headquartered in Baltimore, US.